Dimenhydrinate
Therapeutic agent (verify pharmacological class)
What it is used for
Uses for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness Clinical selection for Dimenhydrinate should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Warnings Do not use for children under 2 years of age unless directed by a doctor. Ask a doctor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product marked drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Possible side effects
Drowsiness; psychomotor impairment; anti-muscarinic effects [e.g. urinary retention; dry mouth; GI disturbances; blurred vision]; allergic reactions; epileptic form seizure in patients with cerebral cortex focal lesion; muscle weakness; tachycardia; tight chest; paradoxical CNS stimulation - mostly in children.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.